Design and multi-step synthesis of chalcone-polyamine conjugates as potent antiproliferative agents. 2017

Benjamin Rioux, and Christelle Pouget, and Chloë Fidanzi-Dugas, and Aurélie Gamond, and Aurélie Laurent, and Josiane Semaan, and Aline Pinon, and Yves Champavier, and David Y Léger, and Bertrand Liagre, and Jean-Luc Duroux, and Catherine Fagnère, and Vincent Sol
Université de Limoges, Laboratoire de Chimie des Substances Naturelles, EA 1069, F-87000 Limoges, France.

The aim of this study is to synthesize chalcone-polyamine conjugates in order to enhance bioavailability and selectivity of chalcone core towards cancer cells, using polyamine-based vectors. 3-hydroxy-3',4,4',5'-tetramethoxychalcone (1) and 3',4,4',5'-tetramethoxychalcone (2) were selected as parent chalcones since they were found to be efficient anti-proliferative agents on various cancer cells. A series of ten chalcone-polyamine conjugates was obtained by reacting carboxychalcones with different polyamine tails. Chalcones 1 and 2 showed a strong cytotoxic activity against two prostatic cancer (PC-3 and DU-145) and two colorectal cancer (HT-29 and HCT-116) cell lines. Then, chalcone-spermine conjugates 7d and 8d were shown to be the most active of the series and could be considered as promising compounds for colon and prostatic cancer adjuvant therapy.

UI MeSH Term Description Entries
D011073 Polyamines Amine compounds that consist of carbon chains or rings containing two or more primary amino groups. Polyamine
D002599 Chalcone An aromatic KETONE that forms the core molecule of CHALCONES. Benzalacetophenone,Benzylideneacetophenone,1,3-Diphenyl-2-Propen-1-One,Chalkone,1,3 Diphenyl 2 Propen 1 One
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Benjamin Rioux, and Christelle Pouget, and Chloë Fidanzi-Dugas, and Aurélie Gamond, and Aurélie Laurent, and Josiane Semaan, and Aline Pinon, and Yves Champavier, and David Y Léger, and Bertrand Liagre, and Jean-Luc Duroux, and Catherine Fagnère, and Vincent Sol
January 2015, Acta pharmaceutica Sinica. B,
Benjamin Rioux, and Christelle Pouget, and Chloë Fidanzi-Dugas, and Aurélie Gamond, and Aurélie Laurent, and Josiane Semaan, and Aline Pinon, and Yves Champavier, and David Y Léger, and Bertrand Liagre, and Jean-Luc Duroux, and Catherine Fagnère, and Vincent Sol
April 2017, Chemical biology & drug design,
Benjamin Rioux, and Christelle Pouget, and Chloë Fidanzi-Dugas, and Aurélie Gamond, and Aurélie Laurent, and Josiane Semaan, and Aline Pinon, and Yves Champavier, and David Y Léger, and Bertrand Liagre, and Jean-Luc Duroux, and Catherine Fagnère, and Vincent Sol
January 2024, Anti-cancer agents in medicinal chemistry,
Benjamin Rioux, and Christelle Pouget, and Chloë Fidanzi-Dugas, and Aurélie Gamond, and Aurélie Laurent, and Josiane Semaan, and Aline Pinon, and Yves Champavier, and David Y Léger, and Bertrand Liagre, and Jean-Luc Duroux, and Catherine Fagnère, and Vincent Sol
January 2015, Anti-cancer agents in medicinal chemistry,
Benjamin Rioux, and Christelle Pouget, and Chloë Fidanzi-Dugas, and Aurélie Gamond, and Aurélie Laurent, and Josiane Semaan, and Aline Pinon, and Yves Champavier, and David Y Léger, and Bertrand Liagre, and Jean-Luc Duroux, and Catherine Fagnère, and Vincent Sol
September 2018, Molecules (Basel, Switzerland),
Benjamin Rioux, and Christelle Pouget, and Chloë Fidanzi-Dugas, and Aurélie Gamond, and Aurélie Laurent, and Josiane Semaan, and Aline Pinon, and Yves Champavier, and David Y Léger, and Bertrand Liagre, and Jean-Luc Duroux, and Catherine Fagnère, and Vincent Sol
January 2024, Chemical biology & drug design,
Benjamin Rioux, and Christelle Pouget, and Chloë Fidanzi-Dugas, and Aurélie Gamond, and Aurélie Laurent, and Josiane Semaan, and Aline Pinon, and Yves Champavier, and David Y Léger, and Bertrand Liagre, and Jean-Luc Duroux, and Catherine Fagnère, and Vincent Sol
February 2023, Archiv der Pharmazie,
Benjamin Rioux, and Christelle Pouget, and Chloë Fidanzi-Dugas, and Aurélie Gamond, and Aurélie Laurent, and Josiane Semaan, and Aline Pinon, and Yves Champavier, and David Y Léger, and Bertrand Liagre, and Jean-Luc Duroux, and Catherine Fagnère, and Vincent Sol
November 2014, Molecules (Basel, Switzerland),
Benjamin Rioux, and Christelle Pouget, and Chloë Fidanzi-Dugas, and Aurélie Gamond, and Aurélie Laurent, and Josiane Semaan, and Aline Pinon, and Yves Champavier, and David Y Léger, and Bertrand Liagre, and Jean-Luc Duroux, and Catherine Fagnère, and Vincent Sol
May 2021, Bioorganic chemistry,
Benjamin Rioux, and Christelle Pouget, and Chloë Fidanzi-Dugas, and Aurélie Gamond, and Aurélie Laurent, and Josiane Semaan, and Aline Pinon, and Yves Champavier, and David Y Léger, and Bertrand Liagre, and Jean-Luc Duroux, and Catherine Fagnère, and Vincent Sol
November 2020, Molecules (Basel, Switzerland),
Copied contents to your clipboard!